Critics Warn TrumpRx Will Further Enrich Big Pharma, Not Reduce Drug Prices

Source: Truthout · Bias: Far Left

Summary

Trump’s son is on the board of a prescription drug platform that may benefit from new direct-to-patient medicine sales policies.

Related Coverage

More Headlines From February 6, 2026

Critics Warn TrumpRx Will Further Enrich Big Pharma, Not Reduce Drug Prices
Truthout

Critics Warn TrumpRx Will Further Enrich Big Pharma, Not Reduce Drug Prices

Far Left

Trump’s son is on the board of a prescription drug platform that may benefit from new direct-to-patient medicine sales policies.